Patient knowledge and control of type 2 diabetes.

被引：0
作者：
Le, TT [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2005年 / 53卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
141
引用
收藏
页码：S102 / S102
页数：1
相关论文
共 50 条
[21]   Hepatic lipase and glycemic control in type 1 diabetes. [J].
Sibley, SD ;
Purnell, JQ ;
Hirsch, IB ;
Palmer, JP ;
Cleary, PA ;
Brunzeil, JD .
JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (05) :264A-264A
[22]   Improving glucose control and cardiovascular risk in general practice Type 2 diabetes. [J].
Potts, NJ ;
Holman, RR .
DIABETOLOGIA, 2003, 46 :A441-A441
[23]   III. Prevention and control strategies to combat the rise of Type 2 Diabetes. [J].
Violante-Ortiz, Rafael .
GACETA MEDICA DE MEXICO, 2009, 145 (04) :295-298
[24]   Acarbose improves glycaemic control in patients with insulin - Treated type 2 diabetes. [J].
Simpson, H ;
Robertson-Mackay, F ;
Montegriffo, E ;
Fox, C .
DIABETOLOGIA, 1999, 42 :A223-A223
[25]   Recurrent hypoglycemia in a patient with type 2 diabetes. Interdisciplinary clarification of a potentially artificial disorder [J].
Hellen, F. ;
Kuehn, M. C. ;
Janssen, B. ;
Hartung, B. .
RECHTSMEDIZIN, 2013, 23 (05) :404-406
[26]   Role of the kidney in hyperglycemia in type 2 diabetes. [J].
Meyer C. ;
Gerich J.E. .
Current Diabetes Reports, 2002, 2 (3) :237-241
[27]   Mechanism of action of thiazozidinediones in type 2 diabetes. [J].
Levin, K ;
Beck-Nielsen, H .
INSULIN RESISTANCE, METABOLIC DISEASES AND DIABETIC COMPLICATIONS, 1999, 1177 :243-251
[28]   Diet and risk of type 2 diabetes. Reply [J].
Hu, FB ;
Manson, JE ;
Willett, WC .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :297-298
[29]   Rosiglitazone, PPAR(gamma), and Type 2 Diabetes. [J].
Kahn, Barbara B. ;
McGraw, Timothy E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (27) :2667-2669
[30]   Calpain 10 and genetics of type 2 diabetes. [J].
Cox N.J. .
Current Diabetes Reports, 2002, 2 (2) :186-190
12345